Les Meilleurs doctors à Istanbul - TOP-43 des

Uzmanlıklar

• Kilo verme / Alma programları
• Bariatrik Cerrahide Beslenme
• Diyabette Beslenme
• Çocuk Dönemi Beslenme
• Gebelik Döneminde Beslenme
• Kalp ve Damar Hastalıklarında Beslenme
• Sindirim Sistemi Hastalıklarında Beslenme
• Sporcu Beslenmesi

Deneyim

• Antalya RenovaFit Özel Spor Salonu 2017
• Beslenme ve Diyet Danışmanlığı Özel Klinik Diyetisyenliği 2019-2023
• BAH

Eğitim

• Akdeniz Üniversitesi

Lefke Avrupa Üniversitesi

Bilimsel Yayınlar

• Kalp Dostu Beslenme
• Yeme Bozukluklarında (Anoreksiya ve Bulimia Nervoza)
• Gelecek Nasıl Beslenecek
• Kahvaltının Önemi
• Psikodiyet ;Beslenmenin Psikolojisi
• Dünya Diyetlerine Genel Bakış ; Alkali
• Emzirme Döneminde Beslenme
• Bariatrik Cerrahide Beslenme
• Yeme Bozukluklarından Obeziteye Bilimsel Yaklaşım
• Palyatif Bakım Tedavileri
• Beden Dili Eğitimi
• Diksiyon ve Etkili Konuşma

Medical aesthetics is a specialized field of medicine that focuses on improving cosmetic appearance through the treatment of conditions including scars, skin laxity, wrinkles, moles, liver spots, excess fat, cellulite, unwanted hair, skin discoloration and spider veins. In Istanbul, Turkey, medical aesthetics encompasses a broad range of non surgical procedures that aim to enhance an individual’s appearance and boost their self confidence.

• Injectables: Including Botox and dermal fillers to reduce the appearance of wrinkles and to plump up the skin.
• Laser Treatments: Utilized for hair removal, skin resurfacing, and to diminish the visibility of scars or pigmentation.
• Skin Rejuvenation: Such as chemical peels, microneedling, and light therapy to improve skin texture and tone.

EXPERIENCE*

2019 - Present, Istanbul/Istanbul/Turkey

MEMORIAL ATAŞEHİR HOSPITAL

General Surgeon

2012 - 2019, Diyarbakır/Diyarbakır/Turkey

DİCLE UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2011 - 2012, Van/Van/Turkey

VAN REGIONAL TRAINING AND RESEARCH HOSPITAL

General Surgeon

2009 - 2011, Van/Van/Turkey

HAKKARİ STATE HOSPITAL

General Surgeon

2004 - 2009, Van/Van/Turkey

YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2002 - 2004, Van/Van/Turkey

HACIBEKİR HEALTH CENTER

General Practitioner

*EDUCATION*

2018 - 2019, Diyarbakır/Turkey

Associate Professor

2015, Ohio/USA

OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

Neck Dissection Training

2012 - 2018, Diyarbakır/Turkey

Assistant Professor

1996 - 2002, Adana/Turkey

ÇUKUROVA UNIVERSITY

FACULTY OF MEDICINE - Medical Doctor Education

Education:

• Degree: Faculty of Medicine, Trakya University, 2009
• Medical Specialty: Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, 2010-2014
• Specialist Doctor: Internal Medicine, Kanuni Sultan Süleyman Training and Research Hospital, 2014-2019
• Specialist Doctor: Internal Medicine, Turkish Hospital Internal Medicine Clinic, Qatar, 2019-2020
• Specialist Doctor: Internal Medicine, Istanbul Medipol University Hospital Mega Hospital Internal Medicine Department, 2020-2024
• Associate Professor Doctor: Internal Medicine, Istanbul Medipol University Medipol Acıbadem Regional Hospital, 2024-Present.

Roles in Projects:

Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.

Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.

Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.

Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).

Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.